- €2.10bn
- €2.39bn
- €839.62m
- 88
- 40
- 46
- 63
Annual income statement for Melexis NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 644 | 836 | 964 | 933 | 840 |
| Cost of Revenue | |||||
| Gross Profit | 264 | 358 | 423 | 383 | 324 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 495 | 610 | 703 | 713 | 706 |
| Operating Profit | 148 | 227 | 261 | 220 | 134 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 154 | 238 | 253 | 205 | 136 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 131 | 197 | 209 | 171 | 113 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 131 | 197 | 209 | 171 | 113 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 131 | 197 | 209 | 171 | 113 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.36 | 4.99 | 5.33 | 4.39 | 2.78 |
| Dividends per Share |